H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 6.9% of adults in Bellevue have diagnosed diabetes — 5.1 points below the U.S. 12% figure. Census population 151,854. Washington Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Bellevue clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Bellevue storefront.
Non-Surgical Regenerative Therapy Options in Bellevue, WA for clinics & physicians. Give patients non-surg… Compliance support & pricing — contact Hawk Medical.
5.4% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 6.9% of adults in Bellevue have diagnosed diabetes — 5.1 points below the U.S. 12% figure. Population 151,854. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JF documentation are ready before the first application of non surgical regenerative therapy.
National Non-Surgical Regenerative Therapy Options notes (how the product actually works)Three grains, kept separate on purpose. City: Census 151,854 and CDC PLACES crude rates. State: Washington State Department of Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and Noridian Healthcare Solutions LCDs. CDC PLACES (2023, crude) estimates 6.9% of adults in Bellevue have diagnosed diabetes — 5.1 points below the U.S. 12% figure.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Bellevue trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 6.9% of adults in Bellevue have diagnosed diabetes — 5.1 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 6.9% of adults — 5.1 points below the U.S. 12% figure. Obesity is 18.8%; arthritis is 17.8%. That is place-level BRFSS modeling, not a clinic census and not a Bellevue trial.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Washington.
No. Organization schema on this site does not publish a fake aggregateRating. Testimonials on marketing pages are not assigned to Bellevue as local reviews.
Bring specialty, monthly joint / regenerative volume, and whether you bill JF FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 6.9% diabetes and 17.8% arthritis for Bellevue — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Bellevue, WA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Bellevue is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Bellevue — 5.1 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Washington Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, OR, SD, UT, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Bellevue. Useful for joint-program math; still needs a diagnosis and privileging.
No Bellevue storefront. Joe Bradley is an active practice owner. non surgical regenerative therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.